PEDIATRIC DERMATOLOGICAL SAFETY OF BABYORGANO HING ROLL-ON: A CLINICAL TRIAL ON HEALTHY HUMAN VOLUNTEERS

The skin irritation potential of BabyOrgano Hing Roll-On, a natural topical remedy designed to alleviate colic and digestive discomfort in infants, was assessed through a single-application patch test on healthy adult human subjects. In this skin irritation potential Clinical trial involving 24 volunteers. Patch testing was performed using three patches: Patch 1 with BabyOrgano Hing Roll-On, Patch 2 as a negative control (0.9% isotonic saline), and Patch 3 as a positive control (1% sodium lauryl sulfate). Patches were applied for 24 hours and skin reactions were evaluated at multiple time points: T0 (baseline), T1 (immediate post-removal), T2 (24 hours post-removal), and T8 (one-week post-removal). Reactions were assessed by both a pediatrician and a dermatologist using the Draize scale for erythema and oedema. The primary endpoint was the total irritation score 24 hours after patch removal. Results showed no skin irritation (mean score = 0) with Patch 1 and Patch 2, while Patch 3 showed a mean irritation score of 4.33, confirming its expected irritant response. No adverse events, dropouts, or delayed reactions were observed. These findings confirm that BabyOrgano Hing Roll-On is dermatologically safe and non-irritant for application on human skin, supporting its suitability for use in pediatric populations.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-04-16
DOI
https://doi.org/10.5281/zenodo.19592682
Primary Topic
Neonatal skin health care
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

PEDIATRIC DERMATOLOGICAL SAFETY OF BABYORGANO HING ROLL-ON: A CLINICAL TRIAL ON HEALTHY HUMAN VOLUNTEERS

2Baby Organo 1*Dr. Urvi Ashani
Zenodo (CERN European Organization for Nuclear Research)
Neonatal skin health care
article

PEDIATRIC DERMATOLOGICAL SAFETY OF BABYORGANO HING ROLL-ON: A CLINICAL TRIAL ON HEALTHY HUMAN VOLUNTEERS

2Baby Organo 1*Dr. Urvi Ashani
article en

Abstract

The skin irritation potential of BabyOrgano Hing Roll-On, a natural topical remedy designed to alleviate colic and digestive discomfort in infants, was assessed through a single-application patch test on healthy adult human subjects. In this skin irritation potential Clinical trial involving 24 volunteers. Patch testing was performed using three patches: Patch 1 with BabyOrgano Hing Roll-On, Patch 2 as a negative control (0.9% isotonic saline), and Patch 3 as a positive control (1% sodium lauryl sulfate). Patches were applied for 24 hours and skin reactions were evaluated at multiple time points: T0 (baseline), T1 (immediate post-removal), T2 (24 hours post-removal), and T8 (one-week post-removal). Reactions were assessed by both a pediatrician and a dermatologist using the Draize scale for erythema and oedema. The primary endpoint was the total irritation score 24 hours after patch removal. Results showed no skin irritation (mean score = 0) with Patch 1 and Patch 2, while Patch 3 showed a mean irritation score of 4.33, confirming its expected irritant response. No adverse events, dropouts, or delayed reactions were observed. These findings confirm that BabyOrgano Hing Roll-On is dermatologically safe and non-irritant for application on human skin, supporting its suitability for use in pediatric populations.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 5%
Neonatal skin health care
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.